Non-contact resonance testing with the RFR, Part 1: Principles of resonance methods; description and pos­sib­il­it­ies

Non-contact resonance testing in bioenergetic testing methods with the aid of the

By Dr A. Rossaint, Aachen.

(EHK 5 / 2002, pp. 325–333)

In this series of articles (3 in total), I would like to describe the findings of modern physics in relation to resonance testing (medication testing) in bioenergetic regulation methods in general, and in kinesiology in particular, especially autonomic regulation diagnostics (RD, Klinghardt), physioenergetics (PE, V. Assche) and dental PE (ZPE, Rossaint). A new product for non-contact resonance testing—the RFR—provides a welcome and unique aid for all these methods and has already been successfully presented (37) at various universities in Italy and Austria.

The Rossaint Frequency Resonator (RFR), also called the Rossaint Resonator or Rossaint honeycomb, is a novel device for non-contact medication testing (resonance testing) using bioenergetic testing methods, constructed, among other things, according to findings from acupuncture-point biophoton research (V. Benschoten) and scalar-wave physics. It is metal-free, and its components (honeycomb, electrode, tube) are made of acrylic glass (Plexiglas). An additional connecting cable (optical fibre) between the honeycomb and the electrode inside the tube consists of glass fibre or PMMA (Fig. 1). A mini-tube—attached to a second, laterally mounted optical-fibre cable—can also be used to determine energy disturbances at acupuncture points (Rossaint (59, 60)) through kinesiology or by means of RAC or a biotensor (or similar device). (Fig. 1, upper right)

During resonance testing, the tube with its internal electrode (“coaxial cable”) is directed at the patient from a distance of 30–150 cm (or more), and the substances to be tested, such as medications, materials, allergens, etc., are placed in/on the honeycomb. If there is resonance between the test substance and the patient, the examiner can detect changed parameters in the patient using bioenergetic measurement methods, for example a change in arm length (arm-length reflex (AR) after R. V. Assche), muscle strength (muscle test after G. Goodheart, Bi-Digital O-Ring Test after Y. Omura), measured values at acupuncture points (electroacupuncture), or the pulse (RAC after P. Nogier).

If there is no resonance, the above phenomena do not occur.

What is special about the RFR is not only the possibility of performing resonance tests without contact, but also the so-called booster effect, i.e. the patient's energy gain during the test (scalar-wave effect), apparent, for example, in the reduced muscle force (by up to 50% or more) needed to obtain a test response (see above). Tests using the other methods are also more intense and more distinct.

Anyone who works with bioenergetic methods and thus operates within a framework of information medicine knows not only the interconnectedness and diversity of the phenomena involved, but is also more or less aware of the difficulties with various explanatory models. After all, we are dealing with a relatively young discipline that has not yet exhausted its potential for development and explanation, and in which many surprises can still be expected, both regarding diagnostic possibilities as yet unknown and therapeutic successes. Scientifically, despite modern biological findings (morphogenetic fields (Sheldrake)) and physical findings (scalar-wave physics (Meyl), quantum philosophy (Warnke), biophoton research (Popp)), we still face a lack of explanation (though this is due rather to the excessively narrow, purely causal-analytical worldview of natural science). This, however, does not detract from practicability or effectiveness—quite the contrary.

The paradigm shift in general, triggered by the findings of modern physics, and in medicine in particular, is in full swing and has already taken place in experiential medicine (naturopathy).

Behind everything, in any event, there should be a holistic view of the world and thus of the human being, for the understanding of which a “higher, divine perspective is indispensable” (Risi (12), Smith (66)). Alongside functionality, content is also required (law of content and form). (Rossaint (1, 9, 30, 58))

The author has been working with bioenergetic regulation methods for about 30 years, initially with instrument-based methods (e.g. EAV), then increasingly with “hands-on” methods such as auriculomedical and kinesiological techniques. The latter in particular, in addition to practical advantages (no apparatus), also offer sufficient starting points for explanatory models through scalar-wave physics (Meyl) and quantum philosophy (Warnke (53)).

Despite the diversity of all these methods (EAV, BFD, ENT, VRT, ET, Prognos, AM, radiesthesia, radionics, kinesiology, to name only the most important), they all share the use, through their techniques, of appropriate, suitable, so-called resonant remedies, (test) substances and medications for both diagnosis and treatment.

The phenomenon of medication testing is undisputed in experiential medicine and has its foundations in the anatomical and functional structures of the matrix (ground system after Pischinger and Heine), with its proteoglycans, structural glycoproteins, glucosamines and hyperboloids. As a dissipative structure, the matrix constitutes an original information–excitation–conduction system capable of rapid conformational change and thus, as an interface between the worlds of matter and spirit (matter-space, charge-space), makes resonance testing possible in the first place. This occurs particularly through the matrix structures that Heine calls hyperboloids (see below), which, according to Meyl, have the same structure as the “potential vortices” of scalar waves.

While the phenomenon of resonance diagnosis was already known to the Sumerians, Aztecs and Indians—the former, among other things, already distinguished between water physicians and oil physicians, who used subtle-energy methods to test medications and whether water was fit for human consumption—in modern times medication testing, particularly for therapeutic purposes, was rediscovered by Voll and colleagues in the early 1950s.

All “schools” have attempted to validate subjectively perceived results using objective criteria for the resonance phenomena that occur.

As early as the 1970s, attempts were made in EAV to conduct medication testing solely with machines specially constructed for the purpose (Bergold, Euratom), but without success.

Even today it has not been possible to exclude the human component (Lechner (28)). The study presented in 1999 by the EAV Society (Heyer (36)) confirms this, although, as a commendable and noteworthy advance, it succeeded for the first time in having a computer subsequently reproduce improvements in measured values previously achieved by a physician through medication testing.

Those who practise electroacupuncture know that occasionally medications have been found to be suitable—in other words, resonance has occurred—even though the cable connecting the patient to the medication honeycomb was no longer attached. Without our knowing it, this was really the birth of non-contact medication testing (resonance testing), although at the time (the 1970s), in the absence of explanatory models, we tended to be embarrassed when it happened.

At the time, attempts were made to explain the phenomenon by saying that medications act through their electromagnetic field up to a distance of approximately 60 cm and resonate with the electromagnetic field of the person being examined, whereupon resonance produces a change in the measured value, or a different muscle tone is found.

More recent studies in acupuncture-point biophoton research (ABF) by Omura and Van Benschoten showed, however, that information transfer no longer occurred when aluminium foil (approximately 0.3 mm thick) was placed on the examiner's forehead. Of all optical filters placed on the patient's forehead, it could also be interrupted only by an indigo filter, whose associated anatomical region is the forehead. According to V. Benschoten, information transfer is therefore photoelectric in nature.

ABF also found that the signals required for medication testing lie in the near-infrared range between 780 and 1,000 nm; the possibility is also discussed that transmission operates on the principle of UV modulation of an infrared carrier wave (M. M. Van Benschoten / P. U. Eckhoff). This would explain why medication testing over acupuncture points can also be performed through clothing. It encompasses not only visible light but also the UV and IR ranges, and probably more (as experience with the RFR and scalar-wave physics show). Later (Part 2), we shall consider a further plausible explanation through K. Meyl's theory of objectivity (especially potential-vortex theory).

Investigations involving shielding the forehead with the aforementioned indigo filters (or aluminium foil), with the limbic system behind it, which is primarily responsible for the emotional processing of information, showed that the mechanism of information transfer—that is, the patient's / subject's bioinformation—passes through his or her brain waves, is projected into the examiner's frontal cortex and creates a resonance there. Through the interaction between the two people and the medications, this then manifests itself as an unconscious change in the practitioner's muscle tone (or a different contact pressure in electrodiagnostics). (V. Benschoten)

Omura in particular showed that metal hand electrodes no longer had to be placed in the hand, but could instead be placed inside a Plexiglas tube and directed towards the patient at a distance of 30–45 cm to obtain the same results. With this arrangement, information transfer can also be blocked by “closing” the tube opening with the aforementioned indigo filter, i.e. medication testing no longer works if the indigo filter is placed in front of the end of the tube directed towards the patient. This is explained by the fact that this arrangement primarily transmits transverse Hertzian waves and shock waves with, at most, the properties of light (absence of tunnelling; see below).

It is different with the RFR, which mainly uses longitudinal scalar waves as information carriers; in addition to the properties just mentioned, these also have a faster-than-light character (tunnelling; see Part 2).

The RFR was constructed according to the findings of acupuncture-point biophoton research (Omura, V. Benschoten), combined with my own experience of medication testing, and acquired its present form through the findings of scalar-wave physics. (See Part 2.)

From Omura and from kinesiology, particularly PE, the author knew that medications placed locally on the skin are relevant only to that location and its structures, whereas for the whole body a new whole-body somatotopic representation must be created, using an open black ring filter of the kind known from auriculomedicine (Nogier, Bahr). This is placed on the skin during inhalation, causing the energy bodies to focus in the filter as through the eye of a needle and generate this whole-body somatotopic representation. Any medications and substances placed inside the filter then permit statements about effects on the whole body.

In consistently pursuing the ideas above, incorporating the findings that interaction between patient and medication via the physician takes place through biophotons or vortices, and with the basic idea of eliminating all interfering metals if possible, the author successively replaced the individual components of conventional test-set arrangements (brass/silver, copper cable/aluminium honeycomb) with Plexiglas to see whether medication testing (resonance testing) using bioenergetic testing methods, particularly the kinesiological muscle test, AR and Bi-Digital O-Ring Test (BOT, Omura), would still work.

And indeed, it not only worked, it actually worked “better”, i.e. a booster effect occurred (tunnelling effect with scalar waves), especially in diagnosis: muscle testing was easier, required less force, responded faster, and thus became more precise and reliable and more comfortable for the patient. The booster effect with the RFR in particular shows that longitudinal waves (scalar waves) must play a role in both muscle testing and resonance testing (see also Warnke (53)).

If one follows the above ideas and considers the previously customary handling of medication testing (putting medications in the hand or placing them on the body), it becomes apparent that the effect, which is actually only local when something is placed on the body, was mentally “overridden” in favour of a whole-body effect. This shows again that resonance testing is more than a purely physical measurement process and confirms from another perspective how important the human component, with its consciousness, is (see below).

As often happens with new ideas because of Sheldrake's morphogenetic fields, so it was here: after sending out brochures following completion of the Plexiglas testing device and gaining some experience with it, the author learned from Mr Eckhoff (Bünde) that Van Benschoten, too, now worked exclusively with Plexiglas, but did not interpose a glass-fibre cable and placed the tube, without an electrode inside, directly against the honeycomb and directed it towards the patient.

With this arrangement of V. Benschoten's—as also with the arrangement without any tube at all, using only the honeycomb close to the body (0–20 cm)—both of which also work well on the basis of photon transmission at no more than the speed of light (biophotons), the author did not find the booster effect mentioned above (absence of tunnelling; see Part 2); it occurred only when the Plexiglas electrode was additionally placed in the tube.

Likewise, the effective distance to the patient was smaller when the tube (without an electrode) was directly against the honeycomb (30–50 cm), or absent altogether (0–20 cm). However, if the electrode (Plexiglas) is inserted and the tube is moved towards the patient, the distance at which 100% effect is still present can be extended to 1.5 metres or more (depending on the length of the tube and electrode). (Fig. 1, left and upper right)

Depending on the arrangement of the testing station, or when travelling, the last configuration just mentioned is just as suitable as one in which a glass-fibre/synthetic-fibre (PMMA) cable (optical fibre) is interposed between the tube with its electrode (“coaxial cable”; see below) and the honeycomb. (Fig. 1, lower right)

The latter, in turn, has the advantage that the honeycomb can be loaded in a different place (e.g. by an assistant) from where the tube is directed towards the patient. This arrangement can also be used to scan the body, in the sense of direct resonance testing (Omura; see below), for pathologies extending into the cell nucleus. This arrangement is particularly suitable when the patient is lying down, but works equally well standing or, as is generally customary in ZPE, sitting. It also makes it possible to “target” specific organs and zones without moving the entire RFR assembly.

This arrangement is also eminently suitable for bioenergetic information therapy of specific zones, or through the eyes, resulting from the testing (see below).

If the patient's own bodily material, e.g. blood—which contains the patient's complete information—is placed in front of the tube, a diagnosis can likewise be made from it by testing oneself kinesiologically (or with similar methods), e.g. by means of the BOT, and placing the medications to be determined on/in the honeycomb. With perfect resonance (Tesla), resonant interaction (Meyl) (= scalar-wave effect) between bodily material, medication and tester produces a response in the form of the chosen testing method.

If the remedies found are left on/in the honeycomb and the blood in front of the tube, the same resonant interaction, as a scalar-wave effect, also permits “remote treatment” (charge-space, longitudinal waves, virtually instantaneous information transfer), without burdening anyone else or the environment. This is because it is an optimally tuned transmitter–receiver system in the sense of scalar-wave physics, which, because of perfect resonance (Tesla) or resonant interaction (Meyl) (see Parts 2 and 3), permits only this one connection (with the possible exception of identical twins). Klinghardt (33) has found this confirmed.

In the space above and below the honeycomb—bounded by its edges—the signals of substances, medications, etc. introduced there can likewise be detected and used for diagnostic and therapeutic purposes, i.e. the entire honeycomb can be used as a medication pickup and/or information transmitter.

The tube with its internal electrode (when connected to the cable and held up to 15 cm above an area of skin), and the cable alone (when held directly over an area of skin), also permit direct resonance testing (Omura) for organs, meridians and substances (e.g. heavy metals, medications, neurotransmitters and the like). For substances, especially heavy metals, this makes it possible to measure the intracellular burden, or, for medications, to determine the concentration (active level) still present after a time x.

Whereas the first arrangement (tube with internal electrode as a “coaxial cable”, tunnelling, skin contact or up to approximately 15 cm above the skin) provides a measurement reaching into the cell nucleus (including all parts of nuclear DNA), as Schimmel (47, 48) does with his photon resonance test presented in 2001, the second arrangement (PMMA cable alone on the corresponding area of skin) measures the relatively superficial tissue component of the matrix as far as the cell (including protoplasm, cell organelles and mitochondrial DNA, with its special functions (49)).

In order to be able to measure locally as far as the cell nucleus using the cable alone, one cable end was likewise configured as a “coaxial cable” (see Part 2) (= mini-tube) by inserting it into the open connector, so that measurements can now always reach nuclear DNA when these arrangements are used. (Fig. 1, upper right) Corresponding organ/cell components in the form of filters (homeopathically prepared substances, images, names, audio files) are used as information carriers for the corresponding “measurement level” by placing them on/in the honeycomb.

Acupuncture points, too, can be measured extremely well in this way with the booster effect (local booster effect), so that the RFR, in conjunction with a kinesiological, auriculomedical or other bioenergetic method, can also be used as a measuring device for energetic pathologies at acupuncture points (one's own or someone else's), which then have to be more precisely identified etiologically using resonant remedies.

If direct resonance testing is carried out without a “coaxial cable”, i.e. without tunnelling, the resonance levels reached are, as previously with bioenergetic methods, “blood, lymph, organs, organ systems” (Schimmel (47, 48)), i.e. the extracellular space, the matrix, and also the cytoplasm. (See above.)

For direct resonance testing, either the patient holds the cable end at the relevant location to be examined for direct resonance, e.g. at GB 14 for the brain in the case of heavy metals, or a surrogate person does the same while being tested and possibly connected to the system.

“Scanning” with the tube including its electrode (“coaxial cable”) up to approximately 15 cm above the skin also permits identification of two identical substances over a larger area, which can then be delimited very precisely with the cable or mini-tube. With this arrangement, one must be aware that the “range” extends into the cell nucleus.

For this, the substance to be examined, or the histological organ or pathology specimen (as a microscope section or slide), now only needs to be placed on/in the honeycomb, rather than—as with Omura's brass rod and the examined substance in the hand (Fig. 1a)—being held directly above the zone to be examined.

One possible explanatory model for the booster effect is a so-called “photon tunnel”, created by the above-mentioned arrangement inside the tube.

The photon tunnel was discovered only recently (G. Nimtz, Cologne) and states that, when information is transferred through several parallel Plexiglas walls, the information (specific microwaves in the experiment) emerged from the final wall faster than mathematical calculations permitted (according to which no information should initially have emerged on the other side at all). (For details, see Part 2.)

Whether it is exclusively biophotons that make resonance testing possible remains an open question, however. In particular, one must also consider a vortex motion of energy in the sense of Schauberger's implosion (the opposite of explosion), i.e. in the sense of neutrino power (Meyl), which, like noise, is also a scalar-wave phenomenon (see Part 2). Ultimately, one must remember that only a very small spectrum of all radiation is being used, and that the human component (Lechner (28)) is necessary, bringing quite different dimensions into the test arrangement (especially in the sense of the five-body model (32)).

On the basis of the characteristics of the distinction known from quantum philosophy (Warnke (53)) between matter-space (atomic nucleus, electrons, dependent on mass and the speed of light, vectorial, transverse waves, electromagnetic field) and charge-space (virtual energy space, scalar field, independent of mass and the speed of light, longitudinal waves, “vacuum ether”, virtually instantaneous storage and transfer of information), it must be assumed that the latter plays the main role, with the vortex structures arising in these phenomena propagating as longitudinal waves with characteristic patterns. (For a more detailed explanation, see Part 2.)

Since the human being, as an open system, belongs to both spaces, the exchange of information is also an act of mind, which, in my opinion, explains why medication testing (resonance testing) works only by means of the human component mentioned above. In any event, a carrier wave (form wave) (Lecher antenna setting: 7.4) (Kunnen (37)) emerges both within the honeycomb itself and from the tube end directed towards the patient. The waves carried by the various medications inserted into the honeycomb are modulated onto it, thus producing their specific effects in a differentiated manner.

The further the tube is moved towards the outer third of the hand electrode, the longer (greater) the distance that can be maintained between patient / subject and tube without energy loss (100%): at half the approximately 11 cm-long electrode, the measurement distance (100%) is approximately 1.5 m; with almost the entire electrode, approximately 5 m or more (!).

Let us leave scientific explanatory models aside for the moment: what matters in practice is that the system works, has many advantages and—as colleagues have meanwhile confirmed to me without exception—makes testing easier.

Another major advantage of the RFR is that one can test oneself better by directing the tube towards oneself.

By now, the author and a number of users have accumulated a great deal of experience and are repeatedly amazed at the variety of further ways in which the resonance test set can be used and applied.

In practice, it serves not only for ordinary resonance testing of allopathic or homeopathic medications, but can also be used for material testing and allergen identification.

So-called energetic autonosodes (isopathic remedies) can also be produced. This form of application is particularly fascinating. For this purpose, an ampoule containing unmedicated carrier substances, such as seawater, Ringer's solution, a tube of alcohol or unmedicated globules, is placed either in the Plexiglas honeycomb or in front of the tube opening (on the side facing the patient) and left there throughout the entire testing procedure, from history-taking to completed medication testing, including during a psychokinesiological session and treatment. (For a more detailed explanation, see Part 3.)

At the end, a Bionik correlator from Jahoda, Bensheim, or mental means are used to determine which potency of the remedy the patient needs as additional support alongside the tested medications, and it is administered at the potency found for the correspondingly determined period. Sometimes the isopathic “mother tincture” thus obtained is also used when it is identified as suitable by the “processing mudra” (9) in the presence of a parasympathetic muscle response (weak muscle).

The potency level of carrier substances placed in front of the tube is usually higher than that of those left in the honeycomb. If, for example, a D potency was found for the latter, the “tube isopathic remedy” will have a C or LM potency, which the patient then takes in parallel with the other tested medications. It has an astonishingly beneficial, intensifying and supportive effect on the other treatment, especially for psychological-emotional problems, including in Hellinger's sense.

Next, the Rossaint Frequency Resonator can be “connected” to existing testing instruments and testing computers with their virtual programs, as an additional medication honeycomb for substances/preparations not included in the program, by inserting one's own customary or new medications/materials.

This also applies in conjunction with a Möbius loop, if one is used, for example in the Skasys system (28).

Furthermore, the newly developed Plexiglas medication pickup (Fig. 1, left) can be used as usual to “gather” a larger number of ampoules (corresponding to a Kuf series box), before placing the individual ampoules found in the honeycomb. Here too, detection of a resonant remedy extends spatially to approximately the third stacked box or more.

It is also possible to load a honeycomb for a particular indication (e.g. heavy metals or similar) and initially test it as a whole simply by placing it against the basic honeycomb, then, if there is a positive response, identify the individual substances within it. The distance from the device that a medication must not exceed if it is to be detected at all by the test is approximately ½–2 cm (possibly more in individual cases). For docking further honeycombs, this means they should be placed directly against it, or connected using the connectors supplied. It also means, however, that a substance “coincidentally” lying closer than ½–2 cm (possibly more in individual cases) is always included in the test (so beware).

Efficiency, too, just as in the physical experiments (Meyl (3–6, 22)) with the replica of Tesla's “Magnifying Transmitter”, varies with location and with the sensitivity / blockage or degree of consciousness of those involved. Under “poor” conditions, efficiency is only slightly higher (approximately 10–20%); under “good” conditions, correspondingly more (so far up to approximately 80–500%!).

In addition to diagnostic possibilities, the RFR can also be used for therapeutic, purely physical information transfer, both at close range with the tested remedies on the honeycomb while the tube is directed towards the patient, and as “genuine remote treatment” when a substrate belonging to the patient is placed on the honeycomb alongside the remedies. At present, these phenomena, too, can only be explained by scalar waves.

In ZPE, the tube is generally directed towards the patient at shoulder level in order, in accordance with auriculomedicine, to reach both central structures (above the collarbone, higher parasympathetic tone) and peripheral structures (below the collarbone), which have higher sympathetic tone (Strittmatter, Bahr, Nogier). (Fig. 1b)

This also detects any inversion that may be present, i.e. a reversal of the reflex, which in ZPE, just as in auriculomedicine, constitutes an absolute obstacle to diagnosis and treatment (anatomical structure: stellate ganglion with blockage of the first rib).

In choosing materials for fillings/crowns, etc., holistic dentistry must therefore, depending on the intention, direct the tube only centrally or only peripherally: peripherally when new materials are to be tested through the honeycomb, because peripheral placement, by analogy with AM, means adding information, whereas central placement means removing it and is therefore indicated particularly when testing the tolerability of material already present in the mouth. If, for example, gold is placed centrally and an MR / +AR is obtained (especially when a symptom has previously been stored in the biocomputer), the gold acts as a removal, i.e. one then knows that the stored symptom is being maintained by the gold.

Thus, after amalgam removal, for example, central placement can also establish whether symptoms are still being maintained by “amalgam residues”, and appropriate remedies can be prescribed.

Conversely, if the MR (+AR) occurs directly on peripheral placement, one knows that the newly added material is not tolerated. Throughout, it must be remembered that information emerging from the tube end facing the patient acts through approximately 35–45 degrees on each side, i.e. the “dispersion angle” is relatively large. However, a 100% effect is present only within an angle of approximately 10 degrees.

Conversely, this means that no information transfer is obtained when the tube lies crosswise to the patient.

Fundamentally, the RFR has the advantage that medications, materials and test substances are not energetically “loaded” and “contaminated” by direct contact with the patient and the patient's extraneous oscillations.

It is known from Lecher antenna testing (Kunnen) that the metal hand electrode used for resonance testing must be changed every time, because information from the previous patient's medications is still modulated onto it.

In conjunction with the ABT biophoton mudra for yin emission (V. Benschoten) (Fig. 1c), it is also possible to test both whether acupuncture-point treatment as such is indicated and the number of needles, by first inserting a needle into the honeycomb like a medication. The ABT yin mudra—held over PC 6—must then produce no response; otherwise acupuncture is not indicated at that time. The total number of needles up to the next positive response (+AR, MR, VAS) gives the number of needles to be inserted for the particular indication.

Another interesting field of application for the RFR, showing us that the testing process is very complex and must not and cannot be reduced to the physical aspect alone, is the use of mudras and other symbols when these—drawn onto a transparency—are likewise placed on the honeycomb. They then give indications just like a test substance and can be handled in exactly the same way.

The same naturally also applies to microscopic preparations and slides of organs or pathogens.

X-ray images can also be used in this way. Using direct resonance testing with corresponding substances, Omura (45, 46) was able to show scientifically that all structures, whether anatomical (e.g. vessels, nerves) or pathological (e.g. osteitis, tumours, etc.), are imprinted on an X-ray image by the X-rays and can be detected through BOT, AR and MT.

This provides not only the possibility of “screening” an X-ray image, but also of using it to obtain detailed information, inaccessible to the eye, about pathologies if one has the identical substrate suspected as the pathological process. This applies both qualitatively and quantitatively, as is known from direct resonance testing.

In the Indian five-body model, as integrated into RD by D. Klinghardt (32), the last-mentioned applications belong on the third and fourth levels. They show that, if practitioners wish to heal the whole person, they must not take a reductionist approach, but must always take into account the entire “knowing field” (Ulsamer, Hellinger (26)) of the patient and of the room (place) where testing occurs, which corresponds to Sheldrake's morphic fields.

For the honeycomb and tube themselves, this means that they may need to be shielded against interfering radiation, and that the place where they stand must be neutral, e.g. without geopathogenic stimuli (as should be the case for all bioenergetic testing methods), or without objects emitting their own radiation. A suitable base is therefore, for example, a piece of white paper.

The RFR has succeeded in opening a new chapter in all bioenergetic testing methods, especially RD, PE, ZPE and ABT, in order to obtain better, more reliable and, above all, individual results.

You will learn more about the physical background in Part 2, while conclusions by analogy and philosophical considerations are addressed in Part 3.